BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16679321)

  • 1. Essential role of the B23/NPM core domain in regulating ARF binding and B23 stability.
    Enomoto T; Lindström MS; Jin A; Ke H; Zhang Y
    J Biol Chem; 2006 Jul; 281(27):18463-72. PubMed ID: 16679321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.
    Brady SN; Yu Y; Maggi LB; Weber JD
    Mol Cell Biol; 2004 Nov; 24(21):9327-38. PubMed ID: 15485902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.
    Bertwistle D; Sugimoto M; Sherr CJ
    Mol Cell Biol; 2004 Feb; 24(3):985-96. PubMed ID: 14729947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.
    Itahana K; Bhat KP; Jin A; Itahana Y; Hawke D; Kobayashi R; Zhang Y
    Mol Cell; 2003 Nov; 12(5):1151-64. PubMed ID: 14636574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B23 and ARF: friends or foes?
    Lindström MS; Zhang Y
    Cell Biochem Biophys; 2006; 46(1):79-90. PubMed ID: 16943625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA damage disrupts the p14ARF-B23(nucleophosmin) interaction and triggers a transient subnuclear redistribution of p14ARF.
    Lee C; Smith BA; Bandyopadhyay K; Gjerset RA
    Cancer Res; 2005 Nov; 65(21):9834-42. PubMed ID: 16267006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ARF tumor suppressor controls ribosome biogenesis by regulating the RNA polymerase I transcription factor TTF-I.
    Lessard F; Morin F; Ivanchuk S; Langlois F; Stefanovsky V; Rutka J; Moss T
    Mol Cell; 2010 May; 38(4):539-50. PubMed ID: 20513429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.
    Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE
    Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ARF-B23 connection: implications for growth control and cancer treatment.
    Zhang Y
    Cell Cycle; 2004 Mar; 3(3):259-62. PubMed ID: 14726681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer.
    Gjerset RA
    J Mol Histol; 2006 Sep; 37(5-7):239-51. PubMed ID: 16855788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen stimulates the proliferation of human endometrial cancer cells by stabilizing nucleophosmin/B23 (NPM/B23).
    Chao A; Lin CY; Tsai CL; Hsueh S; Lin YY; Lin CT; Chou HH; Wang TH; Lai CH; Wang HS
    J Mol Med (Berl); 2013 Feb; 91(2):249-59. PubMed ID: 22926011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of B23 and EGR1 proteins is functionally linked in tumor cells under stress conditions.
    Ponti D; Bastianelli D; Rosa P; Pacini L; Ibrahim M; Rendina EA; Ragona G; Calogero A
    BMC Cell Biol; 2015 Nov; 16():27. PubMed ID: 26577150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation.
    Ayrault O; Andrique L; Fauvin D; Eymin B; Gazzeri S; Séité P
    Oncogene; 2006 Dec; 25(58):7577-86. PubMed ID: 16924243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribosomal protein S9 is a novel B23/NPM-binding protein required for normal cell proliferation.
    Lindström MS; Zhang Y
    J Biol Chem; 2008 Jun; 283(23):15568-76. PubMed ID: 18420587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical and functional interaction of the p14ARF tumor suppressor with ribosomes.
    Rizos H; McKenzie HA; Ayub AL; Woodruff S; Becker TM; Scurr LL; Stahl J; Kefford RF
    J Biol Chem; 2006 Dec; 281(49):38080-8. PubMed ID: 17035234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the molecular basis of Arf and Hdm2 interactions.
    Bothner B; Lewis WS; DiGiammarino EL; Weber JD; Bothner SJ; Kriwacki RW
    J Mol Biol; 2001 Nov; 314(2):263-77. PubMed ID: 11718560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
    den Besten W; Kuo ML; Williams RT; Sherr CJ
    Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumoylation of nucleophosmin/B23 regulates its subcellular localization, mediating cell proliferation and survival.
    Liu X; Liu Z; Jang SW; Ma Z; Shinmura K; Kang S; Dong S; Chen J; Fukasawa K; Ye K
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9679-84. PubMed ID: 17535915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3.
    Kuo ML; den Besten W; Thomas MC; Sherr CJ
    Cell Cycle; 2008 Nov; 7(21):3378-87. PubMed ID: 18948745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of p14ARF through subnuclear compartmentalization.
    Gjerset RA; Bandyopadhyay K
    Cell Cycle; 2006 Apr; 5(7):686-90. PubMed ID: 16627991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.